Quick Search

 

 


 

 

Result Summary for APV40006

Result Summary
Protocol ID: APV40006
Clinical Study ID: APV40006
Official Title: GW433908 Open Label Study for Subjects with HIV who are Treatment Experienced, on a Failing Regimen or Intolerant to Current Therapy and Sensitive to GW433908
Phase: Phase 4
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Telzer,Telzir,Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.